The Risk of Lung Cancer in Dual Users: A Study

Aug.05.2024

A recent study reported by Patrisnews shows that dual use of traditional tobacco and e-cigarettes may significantly increase lung cancer risk.

According to a report by Patrisnews, a recent study has shown that using traditional tobacco and e-cigarettes together may significantly increase the risk of lung cancer.

From a public health perspective, we are concerned about the dual use of traditional cigarettes and e-cigarettes.

The lead author of this study, Marisa Bittoni, stated.

She is a researcher in oncology at Ohio State University.

Bìtōngní bǔchōng dào: Bìtōngní added:

This study clearly demonstrates that using e-cigarettes while smoking increases the risk of developing lung cancer.

Her research team tracked the e-cigarette and traditional cigarette usage of nearly 5,000 individuals diagnosed with lung cancer in the Columbus area, and compared it with a control group of approximately 27,300 individuals without cancer.

The results showed that people who smoke both types of cigarettes are eight times more likely to develop lung cancer compared to those who do not have cancer.

In addition, the team led by Bithony found that people who smoke both types of cigarettes are four times more likely to develop lung cancer compared to those who only smoke traditional cigarettes.

The research results have recently been published in the Journal of Oncology Research and Therapy.

References:

[1] «Βόμβα» για τους πνεύμονες η παράλληλη χρήση παραδοσιακού και ηλεκτρονικού τσιγάρου

Also Read:

[1] Scientific Study Reveals E-cigarettes Can Alter Human DNA

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Harm Reduction Experts Warn: FCTC COP11 Policies Risk Marginalizing the Global South

Two global tobacco harm reduction experts, in their submission to 2Firsts, argue that several COP11 policy proposals driven by high-income countries do not align with the capacities and conditions of low- and middle-income countries. They highlight research and funding gaps and call for a more equitable global support mechanism.

Nov.19

ceshi1111

Trusted by industry leaders and innovators, ARAC brings unmatched expertise in Modules 5 & 6, including label and claim development, comprehension testing, human factors/usability, and clinical-behavioral research such as actual use and switching studies. These studies generate the robust, real-world evidence needed to evaluate whether products are “Appropriate for the Protection of Public Health” (APPH) -- including randomized experimental longitudinal, actual use, cohort st

Oct.21

RFK Jr. Says Public Should Not Follow His Personal Use of Zyn Nicotine Pouches

According to People, U.S. Health and Human Services Secretary Robert F. Kennedy Jr. said in an interview with The Atlantic that although he frequently uses Zyn nicotine pouches, he does not recommend that Americans imitate his personal habits. His use of nicotine products has drawn renewed attention, alongside ongoing scrutiny of his broader health-related positions.

Dec.04

Sweden on Track to Become Europe’s First Smoke-Free Nation as Snus and Nicotine Pouches Support Declining Smoking Rates

According to Gulf News, Sweden is nearing the World Health Organization’s smoke-free threshold, with daily smoking falling below 5%. Two decades of public health efforts and the growing use of lower-risk alternatives such as Snus and tobacco-free nicotine pouches have contributed to this shift, alongside declines in tobacco-related deaths and lung cancer cases.